Literature DB >> 16777891

Commercial influence and the content of medical journals.

Joel Lexchin1, Donald W Light.   

Abstract

Mesh：

Year:  2006        PMID： 16777891      PMCID： PMC1479665          DOI： 10.1136/bmj.332.7555.1444

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  15 in total

1.  Pharmaceutical advertising revenue and physician organizations: how much is too much?

Authors:  P A Glassman; J Hunter-Hayes; T Nakamura
Journal:  West J Med       Date:  1999-10

2.  A national survey of policies on disclosure of conflicts of interest in biomedical research.

Authors:  S V McCrary; C B Anderson; J Jakovljevic; T Khan; L B McCullough; N P Wray; B A Brody
Journal:  N Engl J Med       Date:  2000-11-30       Impact factor: 91.245

3.  Declaring financial competing interests: survey of five general medical journals.

Authors:  A Hussain; R Smith
Journal:  BMJ       Date:  2001-08-04

4.  Judging the judges: the role of journal editors.

Authors:  J G Ray
Journal:  QJM       Date:  2002-12

5.  Medical journals and pharmaceutical companies: uneasy bedfellows.

Authors:  Richard Smith
Journal:  BMJ       Date:  2003-05-31

6.  Adverts in medical journals: caveat lector.

Authors:  Robert H Fletcher
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321

7.  Journal rejects article after objections from marketing department.

Authors:  Owen Dyer
Journal:  BMJ       Date:  2004-01-31

8.  Editors' declaration of their own conflicts of interest.

Authors:  Irina Haivas; Sara Schroter; Fabian Waechter; Richard Smith
Journal:  CMAJ       Date:  2004-08-31       Impact factor: 8.262

9.  Pharmaceutical advertisements in leading medical journals: experts' assessments.

Authors:  M S Wilkes; B H Doblin; M F Shapiro
Journal:  Ann Intern Med       Date:  1992-06-01       Impact factor: 25.391

10.  Escitalopram (lexapro) for depression.

Authors: 
Journal:  Med Lett Drugs Ther       Date:  2002-09-30       Impact factor: 1.909
View more
  14 in total

Review 1.  Cost effectiveness of anticoagulation in acute coronary syndromes.

Authors:  Jaime Latour-Pérez; Eva de-Miguel-Balsa
Journal:  Pharmacoeconomics       Date:  2012-04       Impact factor: 4.981

2.  Censorship of medical journals.

Authors:  Steve Hickey
Journal:  BMJ       Date:  2006-07-01

Review 3.  Financial ties and concordance between results and conclusions in meta-analyses: retrospective cohort study.

Authors:  Veronica Yank; Drummond Rennie; Lisa A Bero
Journal:  BMJ       Date:  2007-11-16

4.  Should medical journals carry drug advertising? No.

Authors:  Gareth Williams
Journal:  BMJ       Date:  2007-07-14

5.  Is content of medical journals related to advertisements? Case-control study.

Authors:  Vasiliy V Vlassov
Journal:  Croat Med J       Date:  2007-12       Impact factor: 1.351

Review 6.  Responsible authorship in engineering fields: an overview of current ethical challenges.

Authors:  Jason Borenstein
Journal:  Sci Eng Ethics       Date:  2011-04-22       Impact factor: 3.525

7.  The association between a journal's source of revenue and the drug recommendations made in the articles it publishes.

Authors:  Annette Becker; Fatma Dörter; Kirsten Eckhardt; Annika Viniol; Erika Baum; Michael M Kochen; Joel Lexchin; Karl Wegscheider; Norbert Donner-Banzhoff
Journal:  CMAJ       Date:  2011-02-28       Impact factor: 8.262

8.  Conflicts of interest at medical journals: the influence of industry-supported randomised trials on journal impact factors and revenue - cohort study.

Authors:  Andreas Lundh; Marija Barbateskovic; Asbjørn Hróbjartsson; Peter C Gøtzsche
Journal:  PLoS Med       Date:  2010-10-26       Impact factor: 11.069

9.  The patient movement as an emancipation movement.

Authors:  Charlotte Williamson
Journal:  Health Expect       Date:  2008-06       Impact factor: 3.377

10.  Lapses at the new England journal of medicine.

Authors:  Richard Smith
Journal:  J R Soc Med       Date:  2006-08       Impact factor: 18.000
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.